Evidence for a physiological role of prolactin in osmoregulation in the rat after its inhibition by 2-bromo- -ergokryptine.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001966:Bromine / Q000494:pharmacology / Q000627:therapeutic use; D002118:Calcium / Q000652:urine; D004876:Ergot Alkaloids / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006863:Hydrogen-Ion Concentration; D007668:Kidney / Q000187:drug effects / Q000502:physiology; D008297:Male; D009401:Nephrosis / Q000517:prevention & control; D009929:Organ Size; D011188:Potassium / Q000652:urine; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000502:physiology*; D051381:Rats; D012964:Sodium / Q000652:urine; D013997:Time Factors; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D004876:Ergot Alkaloids; D011388:Prolactin; D012964:Sodium; D011188:Potassium; D001966:Bromine; D002118:Calcium